Abstract
Despite enormous advances in clinical medicine, the prognosis of primary malignant brain neoplasms remains dismal. Currently, the most effective therapies result in a median survival of less than one year, with the majority of patients dying within two years (Black, 1991). In order to develop more effective methods for combatting this disease, we took advantage of two biological properties that are critical to glioma growth: first, the observation that malignant gliomas are predominantly a local disease usually recurring within two centimeters of the original focus (Hochberg and Pruitt, 1980); and second, the increasing evidence that brain tumors, like most solid tumors, are angiogenesis-dependent (Brem, et. al., 1988).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Black PM, 1991, Brain Tumors. N Engl J Med 324:1555–1564
Brem H, 1990, Polymers to treat brain tumors. Biomaterials 11:699–701
Brem H, 1990a, Controlled delivery to the brain. in: “Targetting of Drugs 2: Optimization Strategies”, G. Gregoriadis, ed., Plenum Press, New York, pp. 155–163
Brem H, Folkman J, 1975, Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 141:427–439
Brem H, Kader A, Epstein JI, Tamargo RJ, Domb A, Langer R, Leong K, 1989, Biocompatibility of bioerodable controlled release polymers in the rabbit brain. Selective Cancer Therapeutics 5:55
Brem H, Mahaley S, Vick NA, Black KL, Schold C, Burger PC, Freidman AH, Ciric IS, Eller TW, Cozzens JW, Kenealy JN, 1991, Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurgery 74:441–446
Brem H, Patz J, Tapper D, 1983, Detection of human central nervous system tumors: use of migration-stimulating activity of the cerebrospinal fluid. Surg Forum 34:532–534
Brem H, Tamargo RJ, Guerin C, Brem SS, Brem H, 1988, Brain tumor angiogenesis. in: “Advances in Neuro-Oncology”, PL Kornblith and MD Walker, eds., Futura, Mount Kisco, NY. pp. 89–102
Brem H, Tamargo RJ, Pinn M, Chasin M, 1989a, Biocompatibility of a BCNU-loaded biodegradable polymer: a toxicity study in primates. American Association of Neurological Surgeons, Toronto, p. 381
Brem H, Thopmson D, Long DM, Patz A, 1980, Human brain tumors: differences in ability to stimulate angiogenesis. Surg Forum 31:471–473
Brem S, 1976, The role of vascular proliferation in the growth of brain tumors. Clin Neurosurq 23:440–453
Brem S, Cotran R, Folkman J, 1972, Tumor angiogenesis: a quantitative method for histologic grading. J Natl Ca Inst 48:347–356
Brera S, Jensen HM, Gullino PM, 1978, Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 41:239–244
Brera S, Preis I, Langer R, Brera H, Folkman J, 1977, Inhibition of neovascularization by an extract derived from vitreous. Am J Ophthalmol 84:323–328
Chodak GW, Haudenschild C, Gittes RF, Folkman J, 1980, Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann Surg 192:762–771
Folkman J, 1972, Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175:409–416
Folkman J, Klagsbrun M, 1987, Angiogenic factors. Science 235:442–447
Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S, 1983, Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221:719–725
Gimbrone MA, Leapman SB, Cotran RS, Folkman J, 1972, Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136:261–276
Golub LM, Greenwald RA, Ramamurthy NS, McNamara TF, Rifkin BR, 1991, Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med, in press
Golub LM, Ramamurthy N, McNamara TF, Gomes JB, Wolff M, Casino A, Kapoor A, Zambon J, Ciancio S, Schneir M, Perry H, 1984, Tetracyclines inhibit tissue collagenase activity: a new mechanism in the treatment of periodontal disease. J Periodontal Res 19:651
Gross J, Azazkhan RG,-Biswas C, Bruns RR, Hsieh DST, Folkman J, 1981, Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc Natl Acad Sci USA 78:1176–1180
Grossman SA, Reinhard CS, Brem H, Brundrett R, Chasin M, Tamargo R, Colvin OM, 1988, The intracerebral delivery of BCNU with surgically implanted bioerodable polymers: a quantitative autoradiographic study. Proceedings of the American Society of Clinical Oncology 7:84
Hochberg FH, Pruitt A, 1980, Assumptions in the radiotherapy of glioblastoma. Neurology 30:907
Ingber DE, Madri JA, Folkman J, 1986, A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology 119:1768–1775
Langer R, 1990, New methods of drug delivery, Science 249:1527–1533
Langer R, Brem H, Falterman K, Klein M, Folkman J, 1976, Isolation of a cartilage factor that inhibits tumor neovascularization. Science 193:70–72
Langer LF Brem H, Langer R, 1991, New technologies for fighting brain disease. Technology Review Feb/Mar:63–71
Lee JK, Choi B, Sobel RA, Chiocca EA, Martuza RL, 1990, Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisone, J Neurosurg 73:429–435
Libermann TA, Friesel R, Jaye M, Lyall RM, Westermark B, Drohan W, Schmidt A, Maciag T, Schlessinger J, 1987, An angiogenic growth factor is expressed in human glioma cells. EMBO J 6:1627–1632
Maxwell M, Naber SP, Wolfe HJ, Hedley-Whyte ET, Galanopoulos T, Neville-Golden J, Antoniades HN, 1991, Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Ca Res 51:1345–1351
Moringlane JR, Spinas R, Bohlen P, 1990, Acidic fibroblast growth factor (aFGF) is present in the fluid of brin tumor pseodocysts. Acat Neurochir (Wein) 107:88–92
Moses MA, Sudhalter J, Langer R, 1990, Indentification of an inhibitor of neovascularization from cartilage. Science 248:1408–1410
Neuwelt EA, Howieson J, Frenkel EP, Specht HD, Weigel R, Buchan CG, Hill SA, 1986, Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma. Neurosurg 19:573–582
Paulus W, Grothe C, Sensenbrenner M, Janet T, Baur I, Graf M, Roggendorf W, 1990, Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropathol (Berl) 79:418–423
Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H, Hatanaka M, 1990, Gene expression of fibroblast growth factors in human gliomas and meningiomas:demonstration of a cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 87:5710–5714
Tamargo RJ, Bok RA, Brem H, 1991, Angiogenesis inhibition by minocycline. Ca Res 51:672–675
Tamargo RJ, Epstein JI, Reinhard CS, Chasin M, Brem H, 1989, Brain biocompatibility of a biodegradable controlled release polymer in rats, J Biomed Mat Res 23:253
Tamargo RJ, Leong KW, Brem H, 1990, Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate. J Neurooncol 9:131–138
Tamargo RJ, Myseros JS, Brem H, 1988, Growth inhibition of the 9L gliosarcoma by the local sustained release of BCNU: a comparison of systemic versus regional chemotherapy. American Association of Neurological Surgeons, Toronto, p. 399
Tamargo RJ, Olivi A, Bok RA, Brem H, 1991, Angiogenesis inhibition by minocycline, American Association of Neurological Surgeons, New Orleans, p. 525
Tapper D, Langer R, Bellows AR, Folkman J, 1979, Angiogenesis capacity as a diagnostic marker for human eye tumors. Surgery 86:36–40
Taylor CM, Weiss JB, 1985, Partial purification of a 5.7K glycoprotein from bovine vitreous which inhibits both angiogenesis and collagenase activity. Biochem Biophys Res Commun 133:911–916
Weidner N, Semple JP, Welch WR, Folkman J, 1991, Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1–8
Yang MB, Tamargo RJ, Brem H, 1989, Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer, Ca Res, 49:5103
Zagzag D, Miller DC, Sate Y, Rifkin DB, Burstein DE, 1990, Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Ca Res 50:7393–7398
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Guerin, C., Tamargo, R.J., Olivi, A., Brem, H. (1992). Brain Tumor Angiogenesis: Drug Delivery and New Inhibitors. In: Maragoudakis, M.E., Gullino, P., Lelkes, P.I. (eds) Angiogenesis in Health and Disease. NATO ASI Series, vol 227. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3358-0_24
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3358-0_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6481-8
Online ISBN: 978-1-4615-3358-0
eBook Packages: Springer Book Archive